Referencias:

• (2014) Global Tuberculosis Report, , WHO. World Health Organization, Geneva, Switzerland
• Schito, M., Migliori, G.B., Fletcher, H.A., McNerney, R., Centis, R., D'Ambrosio, L., Bates, M., Zumla, A., Perspectives on advances in tuberculosis diagnostics, drugs, and vaccines (2015) Clin Infect Dis, 61, pp. S102-S118. , http://dx.doi.org/10.1093/cid/civ609
• Zumla, A., Chakaya, J., Centis, R., D'Ambrosio, L., Mwaba, P., Bates, M., Kapata, N., Migliori, G.B., Tuberculosis treatment and management-an update on treatment regimens trials new drugs and adjunct therapies (2015) Lancet Respir Med, 3, pp. 220-234. , http://dx.doi.org/10.1016/S2213-2600(15)00063-6
• Zuniga, E.S., Early, J., Parish, T., The future for early-stage tuberculosis drug discovery (2015) Future Microbiol, 10, pp. 217-229. , http://dx.doi.org/10.2217/fmb.14.125
• Sotgiu, G., Centis, R., D'Ambrosio, L., Migliori, G.B., Tuberculosis treatment and drug regimens (2015) Cold Spring Harb Perspect Med, 5, p. a017822. , http://dx.doi.org/10.1101/cshperspect.a017822
• Piuri, M., Jacobs, W.R., Jr., Hatfull, G.F., Fluoromycobacteriophages for rapid, specific, and sensitive antibiotic susceptibility testing of Mycobacterium tuberculosis (2009) PLoS One, 4. , http://dx.doi.org/10.1371/journal.pone.0004870
• Rondón, L., Piuri, M., Jacobs, W.R., Jr., De Waard, J., Hatfull, G.F., Takiff, H.E., Evaluation of fluoromycobacteriophages for detecting drug resistance in Mycobacterium tuberculosis (2011) J Clin Microbiol, 49, pp. 1838-1842. , http://dx.doi.org/10.1128/JCM.02476-10
• Ford, M.E., Stenstrom, C., Hendrix, R.W., Hatfull, G.F., Mycobacteriophage TM4: Genome structure and gene expression (1998) Tuber Lung Dis, 79, pp. 63-73. , http://dx.doi.org/10.1054/tuld.1998.0007
• Piuri, M., Rondon, L., Urdaniz, E., Hatfull, G.F., Generation of affinitytagged fluoromycobacteriophages by mixed assembly of phage capsids (2013) Appl Environ Microbiol, 79, pp. 5608-5615. , http://dx.doi.org/10.1128/AEM.01016-13
• Bardarov, S., Jr., Pavelka, M.S., Jr., Sambandamurthy, V., Larsen, M., Tufariello, J., Chan, J., Hatfull, G., Jacobs, W.R., Jr., Specialized transduction: An efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. Bovis BCG and M. Smegmatis (2002) Microbiology, 148, pp. 3007-3017. , http://dx.doi.org/10.1099/00221287-148-10-3007
• Sambandamurthy, V.K., Jacobs, W.R., Jr., Live attenuated mutants of Mycobacterium tuberculosis as candidate vaccines against tuberculosis (2005) Microbes Infect, 7, pp. 955-961. , http://dx.doi.org/10.1016/j.micinf.2005.04.001
• Jain, P., Hartman, T.E., Eisenberg, N., O'Donnell, M.R., Kriakov, J., Govender, K., Makume, M., Jacobs, W.R., Jr., Phi(2)GFP10, a high-intensity fluorophage, enables detection and rapid drug susceptibility testing of Mycobacterium tuberculosis directly from sputum samples (2012) J Clin Microbiol, 50, pp. 1362-1369. , http://dx.doi.org/10.1128/JCM.06192-11
• Riska, P.F., Jacobs, W.R., Jr., Bloom, B.R., McKitrick, J., Chan, J., Specific identification of Mycobacterium tuberculosis with the luciferase reporter mycobacteriophage: Use of p-nitro-alpha-acetylamino-beta-hydroxy propiophenone (1997) J Clin Microbiol, 35, pp. 3225-3231
• Shawar, R.M., Humble, D.J., Van Dalfsen, J.M., Stover, C.K., Hickey, M.J., Steele, S., Mitscher, L.A., Baker, W., Rapid screening of natural products for antimycobacterial activity by using luciferase-expressing strains of Mycobacterium bovis BCG and Mycobacterium intracellulare (1997) Antimicrob Agents Chemother, 41, pp. 570-574
• Andreu, N., Fletcher, T., Krishnan, N., Wiles, S., Robertson, B.D., Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence (2012) J Antimicrob Chemother, 67, pp. 404-414. , http://dx.doi.org/10.1093/jac/dkr472
• Ollinger, J., Bailey, M.A., Moraski, G.C., Casey, A., Florio, S., Alling, T., Miller, M.J., Parish, T., A dual read-out assay to evaluate the potency of compounds active against Mycobacterium tuberculosis (2013) PLoS One, 8. , http://dx.doi.org/10.1371/journal.pone.0060531
• Franzblau, S.G., DeGroote, M.A., Cho, S.H., Andries, K., Nuermberger, E., Orme, I.M., Mdluli, K., Lenaerts, A.J., Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis (2012) Tuberculosis (Edinb), 92, pp. 453-488. , http://dx.doi.org/10.1016/j.tube.2012.07.003
• Collins, L.A., Torrero, M.N., Franzblau, S.G., Green fluorescent protein reporter microplate assay for high-throughput screening of compounds against Mycobacterium tuberculosis (1998) Antimicrob Agents Chemother, 42, pp. 344-347
• Banaiee, N., Bobadilla-Del-Valle, M., Riska, P.F., Bardarov, S., Jr., Small, P.M., Ponce-De-Leon, A., Jacobs, W.R., Jr., Sifuentes-Osornio, J., Rapid identification and susceptibility testing of Mycobacterium tuberculosis from MGIT cultures with luciferase reporter mycobacteriophages (2003) J Med Microbiol, 52, pp. 557-561. , http://dx.doi.org/10.1099/jmm.0.05149-0

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------